PIM1 and acute lymphoblastic leukemia: Treatment with Pim inhibitors (AZD1208 or TP-3654) in T-ALL or T-LBL patient derived xenograph mice models carrying the TCRβ-PIM1+ translocation or high Pim-1 expression levels caused tumor growth to be substantially inhibited [163].